Literature DB >> 16075219

Late-onset retinal dystrophy in alpha-mannosidosis.

Christina Springer1, Alexander Gutschalk, Hans-Michael Meinck, Klaus Rohrschneider.   

Abstract

alpha-Mannosidosis is a rare lysosomal storage disease that is caused by an inherited deficiency of the lysosomal alpha-mannosidase. Clinical symptoms include coarse facial features, skeletal involvement (dysostosis multiplex), hearing disabilities, mental retardation and hepatosplenomegaly. Only few cases with ocular symptoms have been reported, mainly with lenticular opacities. We report on two brothers with complex neurological symptoms who presented with late-onset retinal dystrophy and were followed up for 6 years.

Entities:  

Mesh:

Year:  2005        PMID: 16075219     DOI: 10.1007/s00417-004-1084-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Clinical and biochemical analysis of two families with type I and type II mannosidosis.

Authors:  J K Bennet; P P Dembure; L J Elsas
Journal:  Am J Med Genet       Date:  1995-01-02

2.  Ocular findings in mannosidosis.

Authors:  A I Arbisser; A L Murphree; C A Garcia; R R Howell
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

3.  Oral zinc therapy in the treatment of alpha-mannosidosis.

Authors:  L T Wong; H Vallance; A Savage; A G Davidson; D Applegarth
Journal:  Am J Med Genet       Date:  1993-06-01

4.  Mannosidosis: ocular lesions in the bovine model.

Authors:  R D Jolly; A Shimada; R R Dalefield; P M Slack
Journal:  Curr Eye Res       Date:  1987-09       Impact factor: 2.424

  4 in total
  2 in total

1.  Retinal and optic nerve degeneration in α-mannosidosis.

Authors:  Juliane Matlach; Thea Zindel; Yasmina Amraoui; Laila Arash-Kaps; Julia B Hennermann; Susanne Pitz
Journal:  Orphanet J Rare Dis       Date:  2018-06-01       Impact factor: 4.123

2.  Natural history of alpha mannosidosis a longitudinal study.

Authors:  Michael Beck; Klaus J Olsen; James E Wraith; Jiri Zeman; Jean-Claude Michalski; Paul Saftig; Jens Fogh; Dag Malm
Journal:  Orphanet J Rare Dis       Date:  2013-06-20       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.